Share-Based Payment Arrangements (Tables)

3 Months Ended

Mar. 30, 2019

Amounts Recognized in Financial Statements with Respect to Plans

Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands):

	Thirteen Weeks Ended
	March 30, 2019			March 31, 2018
Total cost of the Plans during the period	$	1,938		$	3,710
Amount of related income tax benefit recognized during the period		(3,062	)		(2,251	)
Net cost of the Plans during the period	$	(1,124	)	$	1,459

Summary of Information Regarding Stock Options

The following table summarizes information regarding the Company’s outstanding stock options under the Plans:

	Number of Options			Weighted Average Exercise Price per Share		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value (000s)
Options outstanding at December 29, 2018		89,114		$	50.44
Exercised		(16,400	)	$	49.34
Options outstanding at March 30, 2019		72,714		$	50.68		2.9	$	4,269
Options exercisable at March 30, 2019		72,714		$	50.68		2.9	$	4,269

Restricted Stock Units (RSUs)

Schedule of Information on Restricted Stock Units

The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans:

	Number of RSUs			Weighted Average Grant Date Fair Value
Outstanding at December 29, 2018		292,345		$	66.31
Granted		57,548		$	95.71
Shares earned in excess of target (1)		67,729		$	55.94
Vested shares, including shares earned in excess of target		(216,652	)	$	54.29
Forfeited		(3,410	)	$	79.99
Outstanding at March 30, 2019		197,560		$	84.26

(1) Represents shares earned in excess of target under the January 27, 2015 and January 29, 2016 RSU awards as actual results exceeded the target under both awards as a result of fiscal year 2018 results.

Non Vested Restricted Stock and Deferred Stock Units

Schedule of Information on Non-Vested Restricted Stock and Deferred Stock Units

The following table summarizes information regarding the Company’s outstanding shares of non-vested restricted stock and Deferred Stock Units (defined below) under the Plans:

	Number of Shares and Deferred Stock Units			Weighted Average Grant Date Fair Value
Non-vested at December 29, 2018		55,987		$	93.66
Granted		21,050		$	102.83
Vested		(13,772	)	$	85.40
Non-vested at March 30, 2019		63,265		$	98.51